| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 430 | 843 | 144.254 | 214.404 | 554.910 | 826.781 | 979.172 |
| Total Income - EUR | - | - | - | 430 | 843 | 144.404 | 214.404 | 554.952 | 826.782 | 979.095 |
| Total Expenses - EUR | - | - | - | 236 | 1.635 | 122.684 | 188.732 | 480.062 | 715.500 | 852.316 |
| Gross Profit/Loss - EUR | - | - | - | 194 | -792 | 21.720 | 25.673 | 74.890 | 111.282 | 126.779 |
| Net Profit/Loss - EUR | - | - | - | 181 | -817 | 20.278 | 23.785 | 69.616 | 98.317 | 109.537 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - East Pharma Dlt Trade S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 165 | 814 | 878 | 858 | 861 | 0 | 0 |
| Current Assets | - | - | - | 1.266 | -85 | 35.079 | 60.946 | 144.267 | 164.695 | 341.973 |
| Inventories | - | - | - | 0 | 0 | 11.909 | 20.210 | 2.336 | 29.523 | 164.973 |
| Receivables | - | - | - | 430 | 211 | 10.142 | 6.462 | 86.142 | 63.666 | 171.773 |
| Cash | - | - | - | 836 | -295 | 13.028 | 34.275 | 55.789 | 71.506 | 5.227 |
| Shareholders Funds | - | - | - | 224 | -597 | 19.692 | 43.040 | 72.234 | 126.529 | 196.242 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.206 | 1.327 | 16.265 | 18.764 | 72.894 | 38.165 | 145.731 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - East Pharma Dlt Trade S.r.l.